Health Care & Life Sciences » Biotechnology | Genscript Biotech Corp.

Genscript Biotech Corp. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
208
221
805
1,060
995
4,520
Total Accounts Receivable
74
100
202
164
2,034
650
Inventories
11
14
16
33
54
97
Other Current Assets
7
5
8
14
27
53
Total Current Assets
299
340
1,031
1,271
3,110
5,320
Net Property, Plant & Equipment
301
292
293
356
649
1,269
Total Investments and Advances
-
-
-
-
14
88
Intangible Assets
2
3
7
27
31
273
Other Assets
34
64
59
60
80
136
Total Assets
650
716
1,411
1,752
3,942
7,179
ST Debt & Current Portion LT Debt
-
57
-
-
9
Accounts Payable
14
22
19
33
55
Income Tax Payable
20
7
36
44
98
Other Current Liabilities
140
198
185
226
1,970
Total Current Liabilities
232
226
239
304
2,132
Deferred Taxes
14
18
21
35
56
Total Liabilities
232
226
239
308
2,135
Common Equity (Total)
407
479
1,157
1,377
1,703
Total Shareholders' Equity
407
479
1,157
1,377
1,703
Total Equity
408
479
1,157
1,427
1,785
Liabilities & Shareholders' Equity
650
716
1,411
1,752
3,942
Accumulated Minority Interest
-
-
-
50
82
Non-Equity Reserves
11
11
15
18
23

About Genscript Biotech

View Profile
Address
No. 28, Yongxi Road
Nanjing Jiangsu 210000
China
Employees -
Website http://www.genscript.com
Updated 07/08/2019
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services.